Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals

Diabetes Care

Volumn 32, Issue 11, 2009, Pages 2105-2110

  Piemonti, Lorenzo ^a   Calori, Giliola ^a   Lattuada, Guido ^a   Mercalli, Alessia ^a   Ragogna, Francesca ^a   Garancini, Maria Paola ^a   Ruotolo, Giacomo ^a,b   Luzi, Livio ^a,c   Perseghin, Gianluca ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING HABIT;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; ITALY; LEPTIN; LIFE STYLE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE;

EID: 70449412663     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0763     Document Type: Article

References (25)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 14; 1999;340:115-126
2. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999;147:213-225
3. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000;101:2889-2895 (Pubitemid 30415877)
4. Yu H, Zeng Y, Hu J, Li C. Fluid shear stress induces the secretion of monocyte chemoattractant protein-1 in cultured human umbilical vein endothelial cells. Clin Hemorheol Microcirc 2002;26:199-207 (Pubitemid 34748092)
5. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-281 (Pubitemid 128373654)
6. Dawson TC, Kuziel WA, Osahar TA, Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999;143:205-211 (Pubitemid 29138720)
7. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K. Increase of circulating levels of monocyte chemoattractant protein-1 in aging. J Interferon Cytokine Res 1999;19:1179-1182 (Pubitemid 29502785)
8. Parissis JT, Venetsanou KF, Kalantzi MV, Mentzikof DD, Karas SM. Serum profile of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia. Am J Cardiol 2000;85:777-779
9. Garlichs CD, John S, Schmeisser A, Eskafi S, Stumpf C, Karl M, Goppelt-Struebe M, Schmieder R, Daniel WG. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001;104:2395-2400 (Pubitemid 33108370)
10. Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L, Belechri AM, Koukoudis P, Memmos D. Circulating levels of ICAM-1, VCAM-1 and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidemia and vascular events. Nephrol Dial Transplant 2002;17:435-441 (Pubitemid 34211140)
11. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003;107:690-695 (Pubitemid 36222595)
12. de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, Califf RM, Braunwald E. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol 2007;50:2117-2124 (Pubitemid 350117348)
13. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G. Fasting plasma leptin, monocyte chemoattracting protein-1 (MCP-1/CCL2) and α-tumor necrosis factor receptor 2 (α-TNFR-2) concentrations in glucose tolerant and intolerant women: impact on cardiovascular mortality. Diabetes Care 2003;26:2883-2889 (Pubitemid 37205563)
14. Garancini MP, Calori G, Ruotolo G, Manara E, Izzo A, Ebbli E, Bozzetti AM, Boari L, Lazzari P, Gallus G. Prevalence of NIDDM and impaired glucose tolerance in Italy: a OGTT-based population study. Diabetologia 1995;38:306-313
15. Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, Bianchi G, Sica A, Peri G, Melzi R, Aldrighetti L, Secchi A, Di Carlo V, Allavena P, Bertuzzi F. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002;51:55-65 (Pubitemid 34517980)
16. Peri G, Milanese C, Matteucci C, Ruco L, Zhou D, Sozzani S, Coletta I, Mantovani A. A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines: development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods 1994;147:249-257 (Pubitemid 24297156)
17. D'Angelo A, Ruotolo G, Garancini MP, Sampietro F, Mazzola G, Calori G. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population. Haematologica 2006;91:1613-1620 (Pubitemid 46032958)
18. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 2001;86:4776-4781 (Pubitemid 33020519)
19. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004;110:1564-1571 (Pubitemid 39297977)
20. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001;86:3257-3265
21. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276:25096-26100 (Pubitemid 37412988)
22. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-1127
23. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007;97:714-721
24. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr, Larson MG, Vasan RS, Hirschhorn JN, O'Donnell CJ, Murphy PM, Benjamin EJ. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005;112:1113-1120 (Pubitemid 41216117)
25. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr, Kastelein JJP, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207